Li Yi

Executive Director, Formulation and Process Development at Gilead Sciences

San Francisco, California, United States

About

Therapeutic protein formulation scientist Specialties: Monoclonal antibody formulation design; chemical and physical degradation of mAbs and excipients; commercial drug product technology transfer

Experience

  • Executive Director, Biologics Pre-pivotal Formulation and Process Development at Gilead Sciences
    Feb 2024 - Present · 2 yrs 5 mos

  • AbbVie (South San Francisco, California, United States)
    • Center Director
      Aug 2023 - Feb 2024 · 7 mos

    • Director of Pharmaceutical Development
      Nov 2019 - Sep 2023 · 3 yrs 11 mos

  • Genentech (10 yrs 7 mos)
    • Senior Scientist and Group Leader
      Dec 2018 - Nov 2019 · 1 yr

    • Manager, Group Leader
      Feb 2018 - Nov 2019 · 1 yr 10 mos

    • Scientist
      Aug 2013 - Feb 2018 · 4 yrs 7 mos

      Formulation development for late stage clinical trials and commercial; tech transfer of commercial drug products

  • Postdoctoral Fellow at University of Michigan
    Jan 2009 - Apr 2009 · 4 mos

    High throughput assay development for bacterial pathway inhibitor screen.